Operating Expenses Endring Dato
Alaunos Therapeutics USD 8.66M 678K 2023-09
Amgen USD 6.93B 2.11B 2023-12
Arrowhead Research USD 140.1M 15.67M 2023-12
AstraZeneca USD 9.54B 578M 2023-09
Bluebird Bio USD 97.12M 4.93M 2023-09
Bristol-Myers Squibb USD 9.62B 984M 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Heron Therapeutics USD 56.36M 17.8M 2023-09
Incyte USD 826.07M 121.75M 2023-12
Intrexon USD 22.32M 571K 2023-09
Ligand Pharmaceuticals USD 31.56M 1.77M 2023-12
MannKind USD 50.61M 4.46M 2023-12
Merck USD 16.56B 6.35B 2023-12
Peregrine Pharmaceuticals USD 36.62M 3.27M 2023-09
Rigel Pharmaceuticals USD 32.6M 446K 2023-09
Roche Holding CHF 20.02B 5.04B 2023-06
Thermo Fisher Scientific USD 9.03B 322M 2023-12
Veracyte USD 133.71M 11.86M 2023-12
Xencor USD 79.7M 2.27M 2023-12



Intrexon Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.